Home › Funds › Lazard Asset Management › MXCT
Lazard Asset Management position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2025)284.50K sh
Reported value held$620
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 466.60K | $2.21M | New |
| Q3 2022 | 485.10K | $3.15M | Add |
| Q4 2022 | 357.06K | $1.95K | Reduce |
| Q1 2023 | 467.13K | $2.31K | Add |
| Q2 2023 | 470.45K | $2.16K | Add |
| Q3 2023 | 457.37K | $1.43K | Reduce |
| Q4 2023 | 367.13K | $1.73K | Reduce |
| Q1 2024 | 467.69K | $1.96K | Add |
| Q2 2024 | 412.90K | $1.62K | Reduce |
| Q3 2024 | 361.45K | $1.41K | Reduce |
| Q4 2024 | 163.50K | $680 | Reduce |
| Q1 2025 | 146.51K | $399 | Reduce |
| Q2 2025 | 284.50K | $620 | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026
- UBS Group AG 284.27K sh · $349.65K · Q2 2026